Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. logo
SIOX

Sio Gene Therapies, Inc. (SIOX)

$0.3172.96%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.303
Day's Range
$0.335
$0.2303
52-Week Range
$1.53
1 month return4.34%
3 month return2.46%
1 year return78.72%
5 year return85.72%

Company Information

Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Its current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. The company is also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson's disease, which affects millions of patients globally. Led by an experienced team of gene therapy development experts, and supported by collaborations with premier academic, industry and patient advocacy organizations, Sio is focused on accelerating its candidates through clinical trials to liberate patients with debilitating diseases through the transformational power of gene therapies.
OrganizationSio Gene Therapies, Inc.
Employees12
CEOMr. David W. Nassif J.D.
IndustryHealth Technology

Analyst Recommendation

based on 6 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 6 Wall street analysts offering stock ratings for Sio Gene Therapies, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 1477.29%

Current

$0.32

Target

$5.0

Recommendation Trend

Based on 6 analyst

Current1M Ago3M Ago
Buy
6
6
1
Hold
0
1
2
Sell
0
0
4
Consensus
BUY
BUY
SELL

Highlights

Market Capitalization
23.5M
Book Value
$0.66
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.98
Wall Street Target Price
5.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.46
Enterprise Value
-27542684
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.56

Technicals

Beta
1.58
50 Day MA
0.3
200 Day MA
0.4

Institutional Holdings

Rubric Capital Management LP

8.13%

Suvretta Capital Management, LLC

7.99%

Vanguard Group Inc

2.49%

Hudson Bay Capital Management LP

2.27%

Newtyn Management LLC

1.91%

Cladis Investment Advisory LLC

0.75%

Discover more

Frequently Asked Questions

What is Sio Gene Therapies, Inc. share price today?

Can Indians buy Sio Gene Therapies, Inc. shares?

How can I buy Sio Gene Therapies, Inc. shares from India?

Can Fractional shares of Sio Gene Therapies, Inc. be purchased?

What are the documents required to start investing in Sio Gene Therapies, Inc. stocks?

What are today’s High and Low prices of Sio Gene Therapies, Inc.?

What are today’s traded volumes of Sio Gene Therapies, Inc.?

What is today’s market capitalisation of Sio Gene Therapies, Inc.?

What is the 52 Week High and Low Range of Sio Gene Therapies, Inc.?

How much percentage Sio Gene Therapies, Inc. is down from its 52 Week High?

How much percentage Sio Gene Therapies, Inc. is up from its 52 Week low?

What are the historical returns of Sio Gene Therapies, Inc.?

Who is the Chief Executive Officer (CEO) of Sio Gene Therapies, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*